Stephen Daddario
Internal Medicine · St Clair Shores, MINPI 1821006784
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Amgen at 30.6% of the total. Reporting peaked in 2019 at $1,098 and has fallen 98.1% since, to $20 in 2024.
Across 144 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$1K
- Boehringer Ingelheim$593
- Lilly USA, LLC$507
- Novo Nordisk$388
- GSK$171
- Bayer$146
- plus $498 from 14 others
What the payments were for
- Food & beverage$3,27499%
- Other$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 26 | $1,015 |
| Boehringer Ingelheim | 28 | $593 |
| Lilly USA, LLC | 24 | $507 |
| Novo Nordisk | 25 | $388 |
| GSK | 10 | $171 |
| Bayer | 3 | $146 |
| Merck | 7 | $111 |
| Johnson & Johnson | 5 | $82 |
| Sanofi | 3 | $52 |
| Baxter Healthcare | 1 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Pfizer | 2 | $33 |
| AbbVie | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Abbott | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,319 in reported general payments places this provider in the 85th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 20 | $443 |
| Atorvastatin Calcium | 12 | $205 |
| Amlodipine Besylate | 14 | $121 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in St Clair Shores
- Terry SmithAnn Arbor$2.3M
- Michael ValituttoKalamazoo$1.8M
- Ulka VaishampayanAnn Arbor$996K
- Tina AbrahamPontiac$834K
- Steven KatzmanLivonia$715K
- Adam FormanSouthfield$453K
- Saroj NeupaneDetroit$373K
- James BazziDearborn Heights$368K
- Mohamad HatahetWaterford$352K
- A FendrickAnn Arbor$347K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.